Gestational diabetes risk in a multi-ethnic population.


Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 02 06 2019
accepted: 06 08 2019
pubmed: 9 9 2019
medline: 14 7 2020
entrez: 9 9 2019
Statut: ppublish

Résumé

To compare gestational diabetes mellitus (GDM) risk among two ethnic minority groups, with high type-2 diabetes (T2DM) prevalence, as compared to the Jewish population majority group. A historical cohort study was conducted using clinical data collected between January 1, 2007, and December 31, 2011. The study sample included 20-45-year-old women; 2938 Ethiopian, 5849 Arab and 5156 non-Ethiopian Jewish women. GDM was defined according to the two-step strategy: step 1: glucose ≥ 140 mg/dl and step 2: using Coustan and Carpenter's diagnostic criteria. GDM risk was tested in a multivariable model, adjusted for age, parity and pre-gestational values of the metabolic syndrome components. Mean body mass index (BMI) values and morbid obesity rates were lowest among Ethiopian women and highest among Arab women. The prevalence of pre-gestational diabetes was significantly higher among Ethiopian (2.7%) and Arab (4.1%) women than among non-Ethiopian Jewish women (1.6%), and GDM screening rates were relatively high (85.5%, 87.2% and 83%, respectively). The proportion of pregnancies complicated with GDM was higher among Ethiopian women (4.3%) but not significantly different between Arab (2.9%) and non-Ethiopian Jewish (2.2%) women. In multivariable analysis, GDM was associated with Ethiopian ancestry (OR, 2.55; 95% CI, 1.60-4.08), adjusted for age, BMI, plasma triglyceride level and parity. Arab ethnicity was not significantly associated with GDM risk in multivariable analysis. Both Ethiopian and Arab minority ethnicities have a higher risk of T2DM in comparison with other Israeli women, but only Ethiopian origin is an independent risk factor for GDM while Arab ethnicity is not.

Identifiants

pubmed: 31494746
doi: 10.1007/s00592-019-01404-8
pii: 10.1007/s00592-019-01404-8
pmc: PMC7049543
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

263-269

Références

J Diabetes. 2015 Jul;7(4):531-9
pubmed: 25223990
Cardiovasc Diabetol. 2016 May 05;15:74
pubmed: 27151384
Diabetes Care. 2008 May;31(5):899-904
pubmed: 18223030
J Reprod Med. 1998 Apr;43(4):372-8
pubmed: 9583071
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
Am J Clin Nutr. 2007 Aug;86(2):353-9
pubmed: 17684205
Isr J Med Sci. 1993 Jun-Jul;29(6-7):344-6
pubmed: 8349446
Diabetes Care. 2007 Apr;30(4):878-83
pubmed: 17392549
Diabetes Care. 2012 Mar;35(3):526-8
pubmed: 22355019
Ethn Dis. 2009 Autumn;19(4):414-9
pubmed: 20073142
N Engl J Med. 2008 May 8;358(19):1991-2002
pubmed: 18463375
Isr Med Assoc J. 2007 Jul;9(7):525-30
pubmed: 17710784
Am J Obstet Gynecol. 2011 Jul;205(1):55.e1-7
pubmed: 21620361
J Matern Fetal Neonatal Med. 2013 Mar;26(4):412-6
pubmed: 23035769
Am J Obstet Gynecol. 1982 Dec 1;144(7):768-73
pubmed: 7148898
PLoS One. 2017 May 8;12(5):e0176661
pubmed: 28481942
Am J Obstet Gynecol. 2008 Apr;198(4):409.e1-7
pubmed: 18068138
Acta Diabetol. 2019 Jul;56(7):719-721
pubmed: 31119458
Diabetes Care. 2011 Aug;34(8):1791-3
pubmed: 21715521
Diabetes Care. 2012 Sep;35(9):1894-6
pubmed: 22787173
Diabetes Care. 2014 Jun;37(6):1621-8
pubmed: 24705613
Diabetes. 2000 Dec;49(12):2208-11
pubmed: 11118027
Diabetes Care. 2012 Jul;35(7):1492-8
pubmed: 22619080
Diabet Med. 2012 Jun;29(6):748-54
pubmed: 22050554
PLoS One. 2016 Jun 14;11(6):e0157354
pubmed: 27300299
Ann Epidemiol. 2015 Feb;25(2):77-83
pubmed: 25459085
Diabetes Res Clin Pract. 2017 May;127:44-50
pubmed: 28319801
Diabetes Care. 2008 Feb;31(2):340-6
pubmed: 18000174
Diabetes Care. 2019 Mar;42(3):372-380
pubmed: 30655380
Int J Obes (Lond). 2016 Apr;40(4):639-45
pubmed: 26499444
Paediatr Perinat Epidemiol. 2010 Sep;24(5):441-8
pubmed: 20670225
Diabetes Care. 2008 Dec;31(12):2362-7
pubmed: 18809624
JAMA. 1997 Oct 1;278(13):1078-83
pubmed: 9315766

Auteurs

Anat Jaffe (A)

Endocrinology and Diabetes Unit, Hillel Yaffe Medical Center, Hashalom St., 38100, Hadera, Israel. anatjaffe@gmail.com.

Shmuel Giveon (S)

Clalit Health Services, Tel Aviv, Israel.

Carmit Rubin (C)

Information and Computerization Unit, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Ilya Novikov (I)

Information and Computerization Unit, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Arnona Ziv (A)

Information and Computerization Unit, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Ofra Kalter-Leibovici (O)

Unit of Cardiovascular Epidemiology, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
The School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH